MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more
Profile
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
128.78M
P/E Ratio
N/A
Total Cash
157.02M
Projected Growth
N/A
Total Debt
10.4M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.73
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LXEO
Capitalization
129M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
157M
Total Cash/Share
4.73
Total Debt
10.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
139M
P/B Ratio
1.46
Cash Flow
N/A
Earnings
-12.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
5.95
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-84.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-75.77
Shares Held By Institutions
247M
Shares Outstanding - Current
33.2M
Total Liabilities
34.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-41.033
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com